Meyer Colin John

Reata Pharmaceuticals Inc

Chief Innovation Officer

Avg. Two Year Performance

331% Avg. Purchase Return 108% Compound

No Sale Track Record

Holdings: 0 shares

Last Three Months: 21-Jun-24 -- 20-Sep-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Other

Other

Two Year Chart

21-Sep-22 -- 20-Sep-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions